VIP

peptide · evidence: observational · v1.0.0

Description

Vasoactive intestinal peptide discussed in CIRS/neuroinflammation contexts.

Mechanism summary

Neuro-immune and inflammatory signaling.

Reference details

Route(s): intranasal

Tags: immune, neuroinflammation

Active: yes

Dosing references (verbatim from source — not recommendations)

50 mcg per spray intranasally, up to 4 times daily (titrate per CIRS protocol; typically after correcting other abnormalities)

up to 4 times daily · Per provider direction · Per provider direction · intranasal

Source: Practitioner Peptide Dosing Reference (commonly published ranges) — Compiled practitioner reference (internal_protocol) · not yet provider-reviewed

Provider-only reference. This page does not constitute medical advice, a recommendation, or dosing guidance.